BioSpace News Archive

Stempeutics, a leader in allogeneic cellular medicines for inflammatory diseases, announced the publication of the Knee OA Phase 3 trial results in the premier journal, the American Journal of Sports Medicine (AJSM).

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies

The U.S. Food and Drug Administration is announcing the selection of James “Jim” Jones to serve as the first Deputy Commissioner for Human Foods.

PixCell Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for direct capillary sampling with the HemoScreen 5-part differential CBC analyzer, substantially simplifying blood sampling and minimizing the pre-analytical process.

Innovent Biologics, Inc. announces its 2023 interim results and major company business updates.

Glaukos Corporation today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023, at 12:45 p.m. ET in Boston, MA.

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the company will host an Investor Day at the Lewisville, TX headquarters on Wednesday, September 20, 2023 at 1:00pm Central Time.

Dizal today announced that sunvozertinib has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutations.

BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced the expanded availability of its Deep Transcranial Magnetic Stimulation technology in Taiwan.

Verrica’s product YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children .